Sanders Morris Harris’s Pfizer PFE Stock Holding History

Sanders Morris Harris’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$427K	Sell	17,749 -7,144	-29%	-$187K	0.25%	43
2026 Q1	$699K	Buy	+24,893	New	+$663K	0.11%	152
2025 Q4	–	Sell	-13,357	Closed	-$340K	–	228
2025 Q3	$340K	Buy	+13,357	New	+$330K	0.04%	213
2025 Q2	–	Sell	-14,915	Closed	-$373K	–	265
2025 Q1	$373K	Hold	14,915	–	–	0.06%	183
2024 Q4	$396K	Sell	14,915 -1,000	-6%	-$27.1K	0.06%	187
2024 Q3	$461K	Buy	15,915 +1,200	+8%	+$35K	0.08%	167
2024 Q2	$412K	Hold	14,715	–	–	0.07%	179
2024 Q1	$408K	Buy	+14,715	New	+$408K	0.08%	180
2023 Q4	–	Sell	-78,770	Closed	-$2.65M	–	224
2023 Q3	$2.65M	Buy	78,770 +64,055	+435%	+$2.27M	0.54%	31
2023 Q2	$540K	Buy	14,715 +6,460	+78%	+$251K	0.12%	127
2023 Q1	$337K	Sell	8,255 -6,216	-43%	-$268K	0.12%	82
2022 Q4	$741K	Hold	14,471	–	–	0.28%	80
2022 Q3	$635K	Hold	14,471	–	–	0.16%	108
2022 Q2	$758K	Hold	14,471	–	–	0.17%	92
2022 Q1	$749K	Hold	14,471	–	–	0.15%	109
2021 Q4	$842K	Hold	14,471	–	–	0.15%	102
2021 Q3	$621K	Sell	14,471 -26,390	-65%	-$1.17M	0.11%	136
2021 Q2	$1.6M	Sell	40,861 -9,977	-20%	-$388K	0.31%	66
2021 Q1	$1.83M	Buy	50,838 +1,016	+2%	+$36.1K	0.39%	47
2020 Q4	$1.84M	Sell	49,822 -2,374	-5%	-$87.1K	0.42%	48
2020 Q3	$1.82M	Buy	+52,196	New	+$1.83M	0.5%	43
2020 Q2	–	Sell	-33,541	Closed	-$580K	–	177
2020 Q1	$580K	Buy	33,541 +7,140	+27%	+$243K	0.57%	46
2019 Q4	$1.01M	Buy	26,401 +5,929	+29%	+$211K	0.23%	110
2019 Q3	$684K	Hold	20,472	–	–	0.17%	122
2019 Q2	$846K	Buy	20,472 +11,573	+130%	+$460K	0.22%	100
2019 Q1	$359K	Sell	8,899 -94	-1%	-$3.77K	0.17%	77
2018 Q4	$372K	Sell	8,993 -328	-4%	-$13.6K	0.2%	69
2018 Q3	$390K	Sell	9,321 -2,144	-19%	-$82.5K	0.18%	80
2018 Q2	$395K	Hold	11,465	–	–	0.18%	81
2018 Q1	$386K	Buy	11,465 +3,235	+39%	+$111K	0.16%	89
2017 Q4	$283K	Hold	8,230	–	–	0.12%	92
2017 Q3	$279K	Hold	8,230	–	–	0.12%	99
2017 Q2	$262K	Sell	8,230 -2,933	-26%	-$92.5K	0.11%	97
2017 Q1	$362K	Hold	11,163	–	–	0.13%	91
2016 Q4	$344K	Sell	11,163 -843	-7%	-$25.7K	0.16%	76
2016 Q3	$385K	Sell	12,006 -2,826	-19%	-$94.5K	0.12%	104
2016 Q2	$495K	Sell	14,832 -21,680	-59%	-$692K	0.12%	145
2016 Q1	$1.03M	Buy	+36,512	New	+$1.04M	0.18%	114

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sanders Morris Harris's PFE Position: Q2 2026 in Review

Sanders Morris Harris reduced its Pfizer (PFE) stake by 29% in Q2 2026, selling an estimated $187K and leaving 17,749 shares worth $427K. The position accounts for 0.25% of the portfolio, ranked #43.

Sanders Morris Harris first reported a position in PFE in Q1 2016 and has held it in 38 quarters since. The position peaked at $2.65M in Q3 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sanders Morris Harris held 17,749 shares of Pfizer worth $427K as of Q2 2026.
Sanders Morris Harris sold 7,144 Pfizer shares in Q2 2026, an estimated $187K.
Pfizer made up 0.25% of Sanders Morris Harris's portfolio in Q2 2026, its #43 holding.
Sanders Morris Harris first reported a position in Pfizer in Q1 2016 and has held it in 38 quarters since.
Sanders Morris Harris's Pfizer position peaked at $2.65M in Q3 2023.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.